Two cycles of the PS-341/bortezomib, adriamycin, and dexamethasone combination followed by autologous hematopoietic cell transplantation in newly diagnosed multiple myeloma patients.

Lee, Jung-Hee

Two cycles of the PS-341/bortezomib, adriamycin, and dexamethasone combination followed by autologous hematopoietic cell transplantation in newly diagnosed multiple myeloma patients. [electronic resource] - European journal of haematology Jun 2012 - 478-84 p. digital

Publication Type: Clinical Trial, Phase II; Journal Article

1600-0609

10.1111/j.1600-0609.2012.01771.x doi


Adult
Aged
Antineoplastic Combined Chemotherapy Protocols--administration & dosage
Boronic Acids--administration & dosage
Bortezomib
Combined Modality Therapy
Dexamethasone--administration & dosage
Doxorubicin--administration & dosage
Female
Hematopoietic Stem Cell Transplantation
Humans
Male
Middle Aged
Multiple Myeloma--drug therapy
Pyrazines--administration & dosage
Thalidomide--administration & dosage
Transplantation, Autologous
Treatment Outcome